HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M A Moro Selected Research

M A Moro Research Topics

Disease

14Stroke (Strokes)
12/2021 - 04/2000
9Ischemia
11/2017 - 05/2000
8Brain Ischemia (Cerebral Ischemia)
06/2014 - 06/2001
8Infarction (Infarctions)
05/2014 - 10/2001
3Ischemic Stroke
11/2022 - 10/2001
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2008 - 04/2007
2Brain Injuries (Brain Injury)
08/2007 - 09/2004
2Necrosis
12/2001 - 06/2001
2Colitis
12/2001 - 06/2001
2Inflammation (Inflammations)
12/2001 - 06/2001
1Atherosclerosis
09/2006
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
09/2006
1Dementia (Dementias)
11/2002
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2001
1Infections
04/2001
1Mitochondrial Diseases (Mitochondrial Disease)
04/2001
1Ulcerative Colitis
05/2000
1Opioid-Related Disorders (Opiate Addiction)
01/2000

Drug/Important Bio-Agent (IBA)

5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2010 - 05/2000
5Glutamic Acid (Glutamate)FDA Link
01/2006 - 05/2000
4Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2004 - 05/2000
3Neuroprotective AgentsIBA
12/2010 - 04/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2006 - 06/2001
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2004 - 10/2001
3Nitric Oxide Synthase (NO Synthase)IBA
06/2001 - 01/2000
2Transcription Factors (Transcription Factor)IBA
06/2014 - 05/2000
2Proteins (Proteins, Gene)FDA Link
06/2014 - 05/2014
2Protein Isoforms (Isoforms)IBA
05/2014 - 09/2004
2Cytidine Diphosphate Choline (Citicoline)IBA
01/2008 - 04/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2007 - 09/2004
2Metalloproteases (Metalloproteinases)IBA
12/2001 - 06/2001
2ADAM17 ProteinIBA
12/2001 - 06/2001
2AcidsIBA
12/2001 - 06/2001
2DisintegrinsIBA
12/2001 - 06/2001
2CytokinesIBA
12/2001 - 06/2001
2Glucose (Dextrose)FDA LinkGeneric
06/2001 - 05/2000
2Oxygen (Dioxygen)IBA
06/2001 - 05/2000
1Tissue Plasminogen Activator (Alteplase)FDA Link
11/2022
1Toll-Like Receptor 4IBA
12/2021
1Angiogenic ProteinsIBA
06/2014
1Messenger RNA (mRNA)IBA
06/2014
1HMGA1a ProteinIBA
06/2014
1CateninsIBA
05/2014
1Leucine (L-Leucine)FDA Link
05/2014
1Phytoestrogens (Phytoestrogen)IBA
07/2012
1Cannabinoid Receptor AgonistsIBA
04/2012
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
04/2012
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2011
1Beclin-1IBA
12/2010
1AdrenomedullinIBA
12/2010
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2010
1salicylhydroxamic acid (SHAM)IBA
12/2010
1Complement Factor H (Factor H)IBA
12/2010
1LipidsIBA
01/2008
1Atorvastatin (Lipitor)FDA Link
08/2007
1GlucocorticoidsIBA
09/2006
1CatecholaminesIBA
09/2006
1Excitatory Amino Acid AntagonistsIBA
01/2006
1lubeluzoleIBA
09/2004
1Peroxidase (Myeloperoxidase)IBA
06/2001
1CalciumIBA
06/2001
1N-(3-(aminomethyl)benzyl)acetamidineIBA
06/2001
1ZincIBA
06/2001
1Peptide Hydrolases (Proteases)FDA Link
06/2001
1Glutathione (Reduced Glutathione)IBA
04/2001
1pimagedine (aminoguanidine)IBA
04/2001
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2000
1NF-kappa B (NF-kB)IBA
05/2000
1Excitatory Amino AcidsIBA
05/2000

Therapy/Procedure

3Therapeutics
11/2022 - 04/2007